Disclosures
Dr. Leino reports no financial relationship with any company whose products are mentioned in this article or with manufacturers of competing products. Dr. Ellingrod receives grant support from the National Institute of Mental Health.
Savvy Psychopharmacology
SSRIs in pregnancy: What should you tell your depressed patient?
Current Psychiatry. 2013 November;12(11):41-42, 44
Author and Disclosure Information
Abbie D. Leino, PharmD
Pharmacy Practice Resident
Johns Hopkins Hospital
Baltimore, Maryland
Vicki L. Ellingrod, PharmD, FCCP
John Gideon Searle Professor of Clinical and Translational Pharmacy
University of Michigan College of Pharmacy and School of Medicine
Ann Arbor, Michigan
Recommended Reading
Related Articles
-
-
Evidence-Based Reviews
Atypical antipsychotics during pregnancy
- Author:
- Thalia Robakis, MD, PhD
- Katherine E. Williams, MD
Make decisions based on available evidence, individualized risk/benefit analysis.
-
Podcasts
Pharmacokinetic considerations when prescribing during pregnancy
- Author:
- Wendy K. Marsh, MD
Wendy K. Marsh, MD
-
Evidence-Based Reviews
Postpartum depression: Help patients find the right treatment
- Author:
- Marlene P. Freeman, MD
Accessibility of treatment, patient preference, breast-feeding help guide decisions
-
Commentary
Depression in pregnancy
Publish date: April 1, 2013